Insights into soluble Toll-like receptor 2 as a downregulator of virally induced inflammation

Frontiers in Immunology

Volumn 7, Issue AUG, 2016, Pages

  Henrick, Bethany M ^a   Yao, Xiao Dan ^b   Taha, Ameer Y ^a   Bruce German, J ^a   Rosenthal, Kenneth Lee ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Inflammation; Innate immunity; Mucosal fluids; Pathogen associated molecular patterns; Pattern recognition receptors; Soluble TLR2; Toll like receptors; Viruses

Indexed keywords

TOLL LIKE RECEPTOR 2;

BACTERIAL CLEARANCE; BACTERIAL INFECTION; BREAST MILK; CELL ACTIVATION; DECISION MAKING; DOWN REGULATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SHORT SURVEY; SIGNAL TRANSDUCTION; VIRUS INFECTION;

EID: 84989322220     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00291     Document Type: Short Survey

References (63)

1. Chuang T, Ulevitch RJ. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta (2001) 1518:157-61. doi:10.1016/S0167-4781(00)00289-X
2. Chuang TH, Ulevitch RJ. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur Cytokine Netw (2000) 11:372-8
3. Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature (1997) 388:394-7. doi:10.1038/41131
4. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA (1998) 95:588-93. doi:10.1073/pnas.95.2.588
5. Takeuchi O, Kawai T, Sanjo H, Copeland NG, Gilbert DJ, Jenkins NA, et al. TLR6: a novel member of an expanding toll-like receptor family. Gene (1999) 231:59-65. doi:10.1016/S0378-1119(99)00098-0
6. Joosten LAB, Abdollahi-Roodsaz S, Dinarello CA, O'Neill L, Netea MG. Toll-like receptors and chronic inflammation in rheumatic diseases: new developments. Nat Rev Rheumatol (2016) 6:1-14. doi:10.1038/nrrheum.2016.61
7. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol (2003) 21:335-76. doi:10.1146/annurev.immunol.21.120601.141126
8. McClure R, Massari P. TLR-dependent human mucosal epithelial cell responses to microbial pathogens. Front Immunol (2014) 5:386. doi:10.3389/fimmu.2014.00386/abstract
9. Haehnel V, Schwarzfischer L, Fenton MJ, Rehli M. Transcriptional regulation of the human toll-like receptor 2 gene in monocytes and macrophages. J Immunol (2002) 168:5629-37. doi:10.4049/jimmunol.168.11.5629
10. Matsushima N, Tanaka T, Enkhbayar P, Mikami T, Taga M, Yamada K, et al. Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors. BMC Genomics (2007) 8:124. doi:10.1186/1471-2164-8-124
11. Zähringer U, Lindner B, Inamura S, Heine H, Alexander C. TLR2-promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology (2008) 213:205-24. doi:10.1016/j.imbio.2008.02.005
12. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science (1999) 285:736-9. doi:10.1126/science.285.5428.736
13. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science (1999) 285:732-6. doi:10.1126/science.285.5428.732
14. Miyake K. Roles for accessory molecules in microbial recognition by Toll-like receptors. J Endotoxin Res (2006) 12:195-204. doi:10.1179/096805106X118807
15. Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik S-G, et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell (2007) 130:1071-82. doi:10.1016/j.cell.2007.09.008
16. Kang JY, Nan X, Jin MS, Youn S-J, Ryu YH, Mah S, et al. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity (2009) 31:873-84. doi:10.1016/j.immuni.2009.09.018
17. Guan Y, Ranoa DRE, Jiang S, Mutha SK, Li X, Baudry J, et al. Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling. J Immunol (2010) 184:5094-103. doi:10.4049/jimmunol.0901888
18. Gay NJ, Keith FJ. Drosophila Toll and IL-1 receptor. Nature (1991) 351:355-6. doi:10.1038/351355b0
19. Cao Z, Henzel WJ, Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science (1996) 271:1128-31. doi:10.1126/science.271.5252.1128
20. Cao X. Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease. Nat Rev Immunol (2016) 16:35-50. doi:10.1038/nri.2015.8
21. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol (1994) 12:141-79. doi:10.1146/annurev.iy.12.040194.001041
22. Matsumoto C, Oda T, Yokoyama S, Tominari T, Hirata M, Miyaura C, et al. Toll-like receptor 2 heterodimers, TLR2/6 and TLR2/1 induce prostaglandin E production by osteoblasts, osteoclast formation and inflammatory periodontitis. Biochem Biophys Res Commun (2012) 428:110-5. doi:10.1016/j.bbrc.2012.10.016
23. Almeida PE, Roque NR, Magalhães KG, Mattos KA, Teixeira L, Maya-Monteiro C, et al. Differential TLR2 downstream signaling regulates lipid metabolism and cytokine production triggered by Mycobacterium bovis BCG infection. Biochim Biophys Acta (2014) 1841:97-107. doi:10.1016/j.bbalip.2013.10.008
24. Patwardhan AM, Akopian AN, Ruparel NB, Diogenes A, Weintraub ST, Uhlson C, et al. Heat generates oxidized linoleic acid metabolites that activate TRPV1 and produce pain in rodents. J Clin Invest (2010) 120:1617-26. doi:10.1172/JCI41678
25. Arnardottir H, Orr SK, Dalli J, Serhan CN. Human milk proresolving mediators stimulate resolution of acute inflammation. Mucosal Immunol (2015) 9:757-66. doi:10.1038/mi.2015.99
26. Nilsen NJ, Vladimer GI, Stenvik J, Orning MPA, Zeid-Kilani MV, Bugge M, et al. A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling. J Biol Chem (2015) 290:3209-22. doi:10.1074/jbc.M114.593426
27. Stack J, Doyle SL, Connolly DJ, Reinert LS, O'Keeffe KM, McLoughlin RM, et al. TRAM is required for TLR2 endosomal signaling to type I IFN induction. J Immunol (2014) 193:6090-102. doi:10.4049/jimmunol.1401605
28. Boehme KW, Guerrero M, Compton T. Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J Immunol (2006) 177:7094-102. doi:10.4049/jimmunol.177.10.7094
29. Leoni V, Gianni T, Salvioli S, Campadelli-Fiume G. Herpes Simplex Virus Glycoproteins gH/gL and gB Bind Toll-Like Receptor 2, and Soluble gH/gL Is Sufficient To Activate NF-κB. J Virol (2012) 86:6555-62. doi:10.1128/JVI.00295-12
30. Chang S, Dolganiuc A, Szabo G. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J Leukoc Biol (2007) 82:479-87. doi:10.1189/jlb.0207128
31. Bieback K, Lien E, Klagge IM, Avota E, Schneider-Schaulies J, Duprex WP, et al. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol (2002) 76:8729-36. doi:10.1128/JVI.76.17.8729-8736.2002
32. Henrick BM, Yao X-D, Rosenthal KL, INFANT Study Team. HIV-1 structural proteins serve as PAMPs for TLR2 heterodimers significantly increasing infection and innate immune activation. Front Immunol (2015) 6:426. doi:10.3389/fimmu.2015.00426
33. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol (2003) 77:4588-96. doi:10.1128/JVI.77.8.4588-4596.2003
34. Ding J, Rapista A, Teleshova N, Mosoyan G, Jarvis GA, Klotman ME, et al. Neisseria gonorrhoeae enhances HIV-1 infection of primary resting CD4+ T cells through TLR2 activation. J Immunol (2010) 184:2814-24. doi:10.4049/jimmunol.0902125
35. Heggelund L, Damås JK, Yndestad A, Holm AM, Muller F, Lien E, et al. Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences. Clin Exp Immunol (2004) 138:116-21. doi:10.1111/j.1365-2249.2004.02595.x
36. Montero Vega MT, de Andrés Martín A. The significance of toll-like receptors in human diseases. Allergol Immunopathol (2009) 37:252-63. doi:10.1016/j.aller.2009.04.004
37. Fischer M, Ehlers M. Toll-like Receptors in Autoimmunity. Ann N Y Acad Sci (2008) 1143:21-34. doi:10.1196/annals.1443.012
38. Liew FY, Xu D, Brint EK, O'Neill LAJ. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol (2005) 5:446-58. doi:10.1038/nri1630
39. LeBouder E, Rey-Nores JE, Rushmere NK, Grigorov M, Lawn SD, Affolter M, et al. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J Immunol (2003) 171:6680-9. doi:10.4049/jimmunol.171.12.6680
40. Henrick BM, Nag K, Yao X-D, Drannik AG, Aldrovandi GM, Rosenthal KL. Milk matters: soluble Toll-like receptor 2 (sTLR2) in breast milk significantly inhibits HIV-1 infection and inflammation. PLoS One (2012) 7:e40138. doi:10.1371/journal.pone.0040138.t001
41. Dulay AT, Buhimschi CS, Zhao G, Oliver EA, Mbele A, Jing S, et al. Soluble TLR2 is present in human amniotic fluid and modulates the intraamniotic inflammatory response to infection. J Immunol (2009) 182:7244-53. doi:10.4049/jimmunol.0803517
42. Kuroishi T, Tanaka Y, Sakai A, Sugawara Y, Komine K-I, Sugawara S. Human parotid saliva contains soluble toll-like receptor (TLR) 2 and modulates TLR2-mediated interleukin-8 production by monocytic cells. Mol Immunol (2007) 44:1969-76. doi:10.1016/j.molimm.2006.09.028
43. Henrick BM, Yao X-D, Drannik AG, Abimiku A, Rosenthal KL, INFANT Study Team. Soluble Toll-like receptor 2 is significantly elevated in HIV-1 infected breast milk and inhibits HIV-1 induced cellular activation, inflammation and infection. AIDS (2014) 28:2023-32. doi:10.1097/QAD.0000000000000381
44. Heggelund L, Flo T, Berg K, Lien E, Mollnes TE, Ueland T, et al. Soluble Toll-like receptor 2 in HIV infection: association with disease progression. AIDS (2004) 18:2437-9
45. Ueland T, Espevik T, Kjekshus J, Gullestad L, Omland T, Squire IB, et al. Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction. J Card Fail (2006) 12:659-63. doi:10.1016/j.cardfail.2006.07.002
46. Candia E, Díaz-Jiménez D, Langjahr P, Núñez LE, la Fuente de M, Farfán N, et al. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients. Immunobiology (2012) 217:634-42. doi:10.1016/j.imbio.2011.10.023
47. Iwaki D, Mitsuzawa H, Murakami S, Sano H, Konishi M, Akino T, et al. The extracellular toll-like receptor 2 domain directly binds peptidoglycan derived from Staphylococcus aureus. J Biol Chem (2002) 277:24315-20. doi:10.1074/jbc.M107057200
48. Raby A-C, Le Bouder E, Colmont C, Davies J, Richards P, Coles B, et al. Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering. J Immunol (2009) 183:506-17. doi:10.4049/jimmunol.0802909
49. Kacerovsky M, Andrys C, Drahosova M, Musilova I, Hornychova H, Lesko D, et al. Soluble toll-like receptor 1 family members in the amniotic fluid of women with preterm prelabor rupture of the membranes. J Matern Fetal Neonatal Med (2012) 25:1699-704. doi:10.3109/14767058.2012.658463
50. Andrys C, Kacerovsky M, Drahosova M, Musilova I, Pliskova L, Hornychova H, et al. Amniotic fluid soluble toll-like receptor 2 in pregnancies complicated by preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med (2013) 26:520-7. doi:10.3109/14767058.2012.741634
51. Kacerovsky M, Musilova I, Jacobsson B, Drahosova M, Hornychova H, Rezac A, et al. Cervical and vaginal fluid soluble toll-like receptor 2 in pregnancies complicated by preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med (2015) 28:1116-22. doi:10.3109/14767058.2014.944859
52. Houssen ME, El-Mahdy RH, Shahin DA. Serum soluble toll-like receptor 2: a novel biomarker for systemic lupus erythematosis disease activity and lupus-related cardiovascular dysfunction. Int J Rheum Dis (2014). doi:10.1111/1756-185X.12452
53. Oever Ten J, Kox M, van de Veerdonk FL, Mothapo KM, Slavcovici A, Jansen TL, et al. The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases. BMC Immunol (2014) 15:55. doi:10.1186/s12865-014-0055-y
54. Langjahr P, Díaz-Jiménez D, la Fuente de M, Rubio E, Golenbock D, Bronfman FC, et al. Metalloproteinase-dependent TLR2 ectodomain shedding is involved in soluble toll-like receptor 2 (sTLR2) production. PLoS One (2014) 9:e104624. doi:10.1371/journal.pone.0104624
55. Huang Z, Ge J, Pang J, Liu H, Chen J, Liao B, et al. Aberrant expression and dysfunction of TLR2 and its soluble form in chronic HBV infection and its regulation by antiviral therapy. Antiviral Res (2015) 118:10-9. doi:10.1016/j.antiviral.2015.03.004
56. Murphy G, Murthy A, Khokha R. Clipping, shedding and RIPping keep immunity on cue. Trends Immunol (2008) 29:75-82. doi:10.1016/j.it.2007.10.009
57. Blobel CP. ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol (2005) 6:32-43. doi:10.1038/nrm1548
58. Chowanadisai W, Lönnerdal B. Alpha(1)-antitrypsin and antichymotrypsin in human milk: origin, concentrations, and stability. Am J Clin Nutr (2002) 76:828-33
59. DeVico AL, Gallo RC. Control of HIV-1 infection by soluble factors of the immune response. Nat Rev Microbiol (2004) 2:401-13. doi:10.1038/nrmicro878
60. Drannik AG, Henrick BM, Rosenthal KL. War and peace between WAP and HIV: role of SLPI, trappin-2, elafin and ps20 in susceptibility to HIV infection. Biochem Soc Trans (2011) 39:1427-32. doi:10.1042/BST0391427
61. Drannik AG, Nag K, Yao X-D, Henrick BM, Sallenave J-M, Rosenthal KL. Trappin-2/elafin modulate innate immune responses of human endometrial epithelial cells to PolyI:C. PLoS One (2012) 7:e35866. doi:10.1371/journal.pone.0035866.g008
62. Smith KA, editor. A Living History of Immunology. Lausanne: Frontiers Media SA (2015)
63. Ledergerber B, Flepp M, Böni J, Tomasik Z, Cone RW, Lüthy R, et al. Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement. J Infect Dis (2000) 181:1280-8. doi:10.1086/315366